SCHEMBL18630396

SCHEMBL18630396

COc1ccc(OCc2cccc(N)c2C=N)c(C=O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.42
KDM4E B2RXH2 2/20 0.42
TUBB1 Q9H4B7 1/20 0.41
ALDH1A1 P00352 4/20 0.39
ERN1 O75460 1/20 0.38
TRIM24 O15164 1/20 0.38
TYR P14679 1/20 0.38
TRIM33 Q9UPN9 1/20 0.38
ATP4A P20648 1/20 0.38
ATP4B P51164 1/20 0.38
MAPT P10636 2/20 0.37
HTT P42858 2/20 0.37
NPC1 O15118 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
LMNA P02545 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
POLB P06746 1/20 0.36
ABCB1 P08183 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18630392 0.84 RAB9A (0.43) RAB9AKDM4ETUBB1ALDH1A1ERN1
SCHEMBL18630395 0.83 KDM4E (0.41) RAB9AKDM4ETUBB1ALDH1A1ERN1
SCHEMBL21755840 0.82 ALDH1A1 (0.34) RAB9ATUBB1ALDH1A1ERN1ATP4A
SCHEMBL18630410 0.79 USP2 (0.42) RAB9AKDM4EERN1MAPTHTT
SCHEMBL23680014 0.77 CDK4 (0.56) RAB9AKDM4ETUBB1ALDH1A1ERN1
SCHEMBL23680018 0.76 RAB9A (0.46) RAB9AKDM4ETUBB1ALDH1A1ERN1
SCHEMBL23680091 0.75 RAB9A (0.46) RAB9AKDM4ETUBB1ALDH1A1ERN1
SCHEMBL29477090 0.74 ERN1 (0.48) RAB9AKDM4ETUBB1ALDH1A1ERN1
SCHEMBL15065581 0.74 ERN1 (0.48) RAB9AKDM4ETUBB1ALDH1A1ERN1
SCHEMBL2573994 0.72 TUBB1 (0.57) RAB9AKDM4ETUBB1ALDH1A1ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4289813-A2 INTERMEDIATES TO OBTAIN SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION Global Blood Therapeutics, Inc. (US) 2023-12-13 EP disclosed
EP-3738434-A1 INTERMEDIATES TO OBTAIN SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION Global Blood Therapeutics, Inc. (US) 2020-11-18 EP disclosed
EP-3141542-A1 SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION Global Blood Therapeutics, Inc. (US) 2017-03-15 EP disclosed